PPS Data Collector Training April 2017

Slides:



Advertisements
Similar presentations
European Centre for Disease Prevention and Control
Advertisements

Infection Prevention and Control Jo Lickiss Nurse Consultant Infection Prevention and Control.
Completing Ward List (Form A) & determining eligible patients for PPS PPS Data Collector Training April 2012 Presentation 2.
Information for Action Point Prevalence Survey of Healthcare associated infection and antimicrobial use 26 th June 2012 Dafydd Williams.
Implementation of Care Bundles at ward level
Hospital Surveillance. Impact of infectious diseases  IDs are considered to be the leading cause of death  Mass population movement  Emerging and re-emerging.
Medication History: Keeping our patients safe. How do we get all of the correct details?
NOSOCOMIAL INFECTION SURVEILLANCE METHODS Masud Yunesian, M.D., Epidemiologist.
Healthcare-associated infections & antimicrobial use in long-term care facilities (HALT) 2013 Training Day: Lecture 1 Welcome & Introduction to HALT 2013.
Fidelma Fitzpatrick Consultant Microbiologist, Health Protection Surveillance Centre & Beaumont Hospital, Dublin, Ireland HPSC, SARI and National HCAI.
Point Prevalence Survey of Hospital- Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2012 Background & Introduction.
Briefing on 4th Meeting of Antimicrobial Resistance National Focal Points Ljubljana (Slovenia), 13 March 2008 Dominique L. Monnet Senior Expert, Antimicrobial.
The epidemiology of HAI Scotland Dr Jacqui Reilly Consultant Epidemiologist Head of HAI and IC Group.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
OVERVIEW AND COMPLETING THE QUESTIONNAIRES - Part 1 LECTURE 2.
PREPARING FOR PARTICIPATION IN HALT-2 LECTURE 6. To outline the steps necessary to prepare successfully for the HALT 2013 PPS. LECTURE OBJECTIVES.
DISCHARGE DEVELOPMENTS ACROSS NORTH GLASGOW OUTPATIENT AND HOME PARENTERAL ANTIBIOTIC THERAPY (OHPAT) SERVICE Lindsay Semple Project Manager/Nurse Specialist.
English Surveillance Programme for Antimicrobial Utilisation and Resistance (ESPAUR) Figures Slideset.
Discharge Pathway Preparation for admission Hospital ward to make contact with the person as far in advance as possible so that arrangements can be made.
ECDC Point prevalence survey of healthcare- associated infections and antimicrobial use in acute care hospitals Forms V4.2.
Jane Stockley Chris Catchpole Carole Clive November 2012.
Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.
Pathway of care for people with learning disabilities Consent to treatment Does the person have the capacity to consent? Can the decision wait until the.
Healthcare-associated infections & antimicrobial use in long-term care facilities (HALT) 2016 Training Day: Lecture 1 Welcome & Introduction to HALT 2016.
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Harm from Invasive Devices Dr. Eleri Davies, Faculty Lead HCAI.
An Audit to Determine if Prescribers are Reviewing Antimicrobial Prescriptions Hours After Initiation. Natalie Holman, Emma Cramp, Joy Baruah Hinchingbrooke.
1 Infectious Diseases in the Nursing Home Setting: Challenges and Opportunities for Clinical Investigation 감염내과 R2 김대호 / Prof. 이미숙 Manisha Juthani-Mehta.
1 Healthcare Associated Infections & Antimicrobial Consumption in Long-Term Care Facilities. (HALT) Mags Moran & Mary Rooney Community Infection Control.
Survey of acute hospital resources for patients with COPD T McCarthy, M O’Connor, on behalf of the National COPD (Respiratory) Strategy Group Population.
ECDC Point prevalence survey of healthcare-associated infections and antimicrobial use in acute care hospitals Forms V4.2.
ECDC Point Prevalence Survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2016–2017 Protocol v5.3 Forms.
Unit Training Topics.
Antibiotics: handle with care!
Improving Infection Prevention & Control Practices
Tackling antimicrobial resistance – what is the current situation in Europe? Dr Andrea Ammon, ECDC Director, 27 June 2017, European Parliament.
EARS-Net data on Antimicrobial Resistance in Ireland, Q
Definition and Use of Clinical Pathways and Case Definition Templates
Welcome Dr. Eleri Davies, Faculty Lead HCAI.
ECDC Point Prevalence Survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2017 Belgian Forms.
HELP US TO PREVENT INFECTIONS SPREADING
Professor Alan Johnson Department of HCAI & AMR
2.13 Copyright UKCS #
GLOBAL POINT PREVALENCE SURVEY
Local organisation of the ECDC PPS
Lehigh Valley Health Network: Community Care Team Compact
Housekeeping.
Interpretation of local, national and European level results
CNISP & CIHI MRSA infection rate comparison Preliminary results
ECDC point prevalence survey (PPS)
Hospital Antibiotic Stewardship Programs
Hospital organization, management, and structure for the infection prevention and control of healthcare-associated infection in Chinese hospitals:
Sources of data (HCAI) Dr Wendy Harrison
Point prevalence survey epidemiology
GLOBAL POINT PREVALENCE SURVEY OF ANTIMICROBIAL CONSUMPTION AND RESISTANCE (GLOBAL-PPS): RESULTS OF ANTIMICROBIAL PRESCRIBING IN INDIA Dr. Sanjeev K Singh.
Presentation Title 36pt Arial Bold
Background and Context
ABMU Antibiotic Audits An Update
PNEUMONIA Team Membership: Susan A . Tuzik, MS, RN
Implementing innovation when financial times are hard
30 JANUARY 2019 PRIVATE HEALTH ESTABLISHMENTS
The Public Health Wales website
Antimicrobial Care Bundle
Reducing Gram-negative bacteraemias: A Scottish Perspective A-Lan Banks Health Protection Scotland March 2019.
Tony Crockford & Muhammad Sartaj.
Point prevalence survey (PPS) of healthcare associated infections (HAI) & antimicrobial use (AMU) in acute care Mark McConaghy, Dr Muhammad Sartaj,
Health Protection Surveillance Centre
EARS-Net results 2011 Ole Heuer
EARS-Net data on Antimicrobial Resistance in Ireland, Q
Preventing Venous Thromboembolism Participating Hospital Survey
Presentation transcript:

Point Prevalence Survey of Hospital-Acquired Infections & Antimicrobial Use in Ireland PPS Data Collector Training April 2017 Background & Introduction to PPS Presentation 1

What is a PPS? A prevalence survey provides data at one particular point in time ‘snapshot’ Prevalence = numerator / denominator Numerator = number of patients on the ward who have an active HAI at the time of the survey Denominator = All eligible patients present on the ward at 8am on the day of the survey for that ward

What is a PPS? PPS team visits a ward at 11am on 10/5/17 29 patients present on the ward at 8am The PPS team decides that 26 patients are eligible for inclusion in the PPS: Two have since been transferred to other wards One has been discharged home

What is a PPS? After completing the PPS for the ward: 9 patients receiving systemic antimicrobials Prevalence of antimicrobial use = 9/26 x 100 = 34.6% 4 patients met case definitions for active HAI HAI prevalence on the ward = 4/26 x 100 = 15.3%

Hospital Infection Society 2006 PPS: Ireland 44 acute hospitals (88%) participated in 2006 PPS 7,541 patients surveyed 369 patients with HCAI HCAI prevalence = 4.9% Systemic antibiotic use prevalence = 34.2%

ECDC 2012 PPS: Ireland 4,532 antimicrobial prescriptions (34%): 50 acute hospitals (42 public & 8 private) 9,030 patients 501 active HAI (5.2%): SSI – 18% Pneumonia – 17% UTI – 15% BSI – 13% & of those, 42% were vascular catheter related CDI – 6% 4,532 antimicrobial prescriptions (34%): 63% IV 78% treatment of infection 11% surgical antimicrobial prophylaxis, of which 47% >24hrs 8% medical prophylaxis Documented indication in 83%

http://www.hpsc.ie/A-Z/MicrobiologyAntimicrobialResistance/InfectionControlandHAI/Surveillance/HospitalPointPrevalenceSurveys/2012/PPS2012ReportsforIreland/

What are the changes in PPS 2017 protocol?

What’s been happening in Ireland since 2012?

Revised PCHCAI Standards to be published in 2017

C. difficile infection (CDI) 2014: National guidelines revised Transition in laboratory testing protocols Enhanced CDI surveillance scheme continues, with increase in participating hospitals 44 (2012) to 53 (2016) National quarterly report issued Quarterly report issued to each participating hospital

Source: HPSC www.hpsc.ie

S. aureus invasive infection Captured via EARS-Net ~99% population coverage Some microbiology laboratories have suspended participation, due to resource issues S. aureus BSI via enhanced surveillance scheme 19 laboratories participated in 2016 23% of MRSA BSI & 20% of MSSA BSI deemed device-related Source: HPSC www.hpsc.ie

Source: HPSC www.hpsc.ie *2016 data are provisional to the end of Q3 only (note: data missing from 2 laboratories for Q3); ‡ 2015 missing data from 3 laboratories for 2 quarters each Source: HPSC www.hpsc.ie

E. faecium Source: HPSC www.hpsc.ie *2016 data are provisional to the end of Q3 only (note: data missing from 2 laboratories for Q3); ‡ 2015 missing data from 3 laboratories for 2 quarters each VRE, vancomycin-resistant enterococcus; VREfm, vancomycin-resistant E. faecium; VSEfm, vancomycin-susceptible E. faecium Source: HPSC www.hpsc.ie

E. coli

Multi-drug resistant K. pneumoniae 1,310 MDRKP cases reported (Q1 2014 – Q3 2016) from 87% of acute hospitals 20% increase in MDRKP reported to Q3 2016 versus same period 2015 2/3 reported in hospitalised patients 59% required treatment of MDRKP infection

CRE 15% of MDRKP also carbapenem resistant 195% increase in carbapenem resistant K. pneumoniae to end Q3 2016 versus 2015 CRE outbreaks in acute hospitals & LTCF From January 2017, MDRKP surveillance replaced by CRE surveillance

+ 90 CPE confirmed Jan – Feb 2017 Data courtesy of Prof M Cormican, CPEARLS

Hospital antimicrobial consumption Source: HPSC www.hpsc.ie

Hospital antimicrobial consumption 2017 PPS will provide you with data on compliance or non-compliance with local restricted use policy Source: HPSC www.hpsc.ie

Source: HPSC www.hpsc.ie

Aims of this PPS To repeat a PPS of HAI & antimicrobial use across all EU Member States during 2016-17 using a common protocol To estimate the total burden of HAI & antimicrobial use within: EU Each Member State Each participating healthcare facility By specialty type By patient type

European PPS: 2011-12 Estimated on any day in Ireland, 494 patients with HAI & 3,289 on antimicrobials Estimated in any year, 20,491 patients in in Ireland with HAI 28

Aims of this PPS To share the results of the PPS with those who need to know: Local Regional National International EU To use the data generated within YOUR hospital to help YOU and your colleagues to: Identify priority areas for future targeted HAI surveillance Identify interventions to prevent HAI Identify areas for targeting antimicrobial stewardship Support business cases for improved IPC, antimicrobial stewardship, surveillance & microbiology laboratory diagnostic resources

Summary Last PPS performed in Ireland five years ago Many interim developments to raise awareness of HAI & need for prudent antimicrobial use 2017 PPS provides us with the opportunity to see where we are now, to direct our future interventions for ongoing improvement in patient care and staffing levels related to IPC, antimicrobial stewardship, surveillance and microbiology laboratory activities

Overview of data to be collected during PPS A1 – PPS team A2 – Night nursing & midwifery staff B – PPS team leader C – PPS team assisted by staff caring for patients

Ward List (Form A1)

Ward List (Form A2)

Hospital Form (Form B)

Hospital Form (Form B)

up to three different hospital-acquired infections Patient Form (Form C) There is space on Form C to record up to five systemic antimicrobial prescriptions AND up to three different hospital-acquired infections

Patient Form (Form C) Use extension sheet Form C Pages 3 & 4 for HAIs 2 & 3 and antimicrobial prescriptions 3, 4, 5

Sections 1, 2, 3 completed for EVERY eligible patient Patient Form (Form C) Two pages for vast majority of patients – extension sheets for patients with ≥2 HAI or ≥3 antimicrobials Five sections: Section 1 – Patient details Section 2 – Risk factors Section 3 – Condition of interest – HAI Y/N & Antimicrobial use Y/N Section 4 – HAI data Section 5 – Antimicrobial use data Sections 1, 2, 3 completed for EVERY eligible patient 100%

Sections 1, 2, 3, 4 completed for EVERY eligible patient Patient Form (Form C) Two pages for vast majority of patients – extension sheets for patients with ≥2 HAI or ≥3 antimicrobials Five sections: Section 1 – Patient details Section 2 – Risk factors Section 3 – Condition of interest – HAI Y/N & Antimicrobial use Y/N Section 4 – HAI data Section 5 – Antimicrobial use data Sections 1, 2, 3, 4 completed for EVERY eligible patient with an active HAI ~ 5 - 10%

Patient Form (Form C) Two pages for vast majority of patients – extension sheets for patients with ≥2 HAI or ≥3 antimicrobials Five sections: Section 1 – Patient details Section 2 – Risk factors Section 3 – Condition of interest – HAI Y/N & Antimicrobial use Y/N Section 4 – HAI data Section 5 – Antimicrobial use data Sections 1, 2, 3 & 5 completed for EVERY eligible patient receiving systemic antimicrobials ~ 33%

Your hospital.... TOTAL NUMBER OF PAPER FORMS TO BE COMPLETED* 150 ACUTE BEDS DIVIDED INTO 8 WARDS 300 ACUTE BEDS DIVIDED INTO 12 WARDS 600 ACUTE BEDS DIVIDED INTO 22 WARDS Ward Lists (Forms A1 & A2) 8 12 22 Hospital Form (Form B) 1 Patient Forms (Form C) 150 300 600 Form C Section 1, 2, 3 Form C (AMU) Section 1, 2, 3 & 5 50 100 200 Form C (HAI) Section 1,2, 3, & 4 15 30 Figures calculated based on estimated prevalence of AMU 33% and HAI 5% *Completed paper versions of all Form A1s, one Form B & all Form Cs are used to enter your hospital’s PPS data onto secure ‘web-based’ data entry system

Patient Form (Form C)

Patient Form (Form C) The answers to 10/12 (83%) questions in Section 1 & 2 can be directly transcribed from the completed Ward List A2 For each eligible patient, the PPS team will need to decide: Admitting consultant’s specialty – prepare and laminate list ahead of PPS & give a copy to each PPS team member Surgical procedure for patients who have had surgery on this admission Underlying disease prognosis – review of notes and talk to ward staff

Patient Form (Form C) ‘Patient on antimicrobials’ on Ward List – BUT double check medication charts – MP, SP could be missed Also check Ward List to identify patients who have undergone surgery in the last 24 hours to pick up surgical antimicrobial prophylaxis administered since 8am yesterday

Patient Form (Form C)

Patient Form (Form C)

Getting ready to do your PPS PPS team identified and trained PPS team leader has hospital code (same as 2012 code) and webform log-in username and password VPN connection tested for webforms data entry Local PPS dates agreed PPS ward schedule prepared & distributed to wards Ward List A1 (one per ward) started in consultation with CNM DONM to request ward CNMs ensure their Ward List A2 completed by 8am on day of PPS

Getting ready to do your PPS Brief night nursing manager on Ward List A2, in case of queries Data gathered for Hospital Form B Ward codes, ward specialty, consultant specialty assigned, local antimicrobial restricted list with laminated copy for each data collector Ward list A2 & Instruction Sheet given to nursing staff on day prior to PPS Sufficient copies of patient forms, protocols available Administrative support identified and trained in form entry Verify PPS data entry on VPN connected PC available

Any Questions? pps2017@hpsc.ie